Variable | Among clients provided misoprostol for induced abortion (n=4924) | |
n | % | |
Age of client (years)†† | ||
≤19 | 965 | 19.6 |
20–24 | 1457 | 29.6 |
25+ | 2498 | 50.8 |
Recorded gestational age of pregnancy (weeks) | ||
<13 | 4220 | 85.7 |
≥13 | 205 | 4.2 |
Missing | 499 | 10.1 |
Misoprostol dose dispensed (μg) | ||
<800 | 533 | 10.8 |
800 | 2313 | 47.0 |
1000–1400 | 132 | 2.7 |
1600–2400 | 792 | 16.1 |
>2600 | 14 | 0.3 |
Missing | 1140 | 23.2 |
Pain management provided | 4876 | 99.0 |
Contraception provided‡ | ||
Short-term method | 3511 | 71.8 |
Long-term method§ | 974 | 19.9 |
No method | 403 | 8.2 |
Abortion outcome | ||
Complete abortion | 4224 | 85.8 |
Abortion with complication managed by PMV | 33 | 0.7 |
Abortion with complication referred to another provider | 174 | 3.5 |
Missing | 493 | 10.0 |
*Data on post abortion care (PAC) clients excluded because of observed limitations in accurate PAC documentation.
†Data on age were missing for four clients.
‡Data on contraception provided were missing for 36 clients.
§Long-term methods included primarily women who received implants and a few who received intrauterine contraceptive devices.
PMV, patent medicine vendor.